Abstract
The aim of our study was to evaluate the benefits of supplementation with 800mg/day of α-tocopherol with regard to cellular viability in HIV-1 seropositive patients undergoing anti-retroviral therapy. A total of 29 patients participated in the study, of whom 14 were given the supplement and 15 a placebo. The analyses were carried out before treatment commenced and after 60, 120 and 180days. The plasma levels ofHIV-1 RNA showed a significant decrease as a consequence of treatment time in the groups studied (p=0.0001), although the difference between the treatments over time was not verified (p=0.7343). The percentage of viable lymphocytes showed a significant increase as a consequence of treatment time in both groups studied (p=0.0002) and a significant difference between the treatments over time (p=0.0472). The percentage of lymphocytes in apoptosis showed a significant reduction over time (p=0.0003), as well as a significant difference between the treatments over time (p=0.0321). The significant increase in cellular viability indicates that supplementation with α-tocopherol offers an additional positive effect on cellular preservation in HIV-1 individuals undergoing anti-retroviral therapy; however, it represents an additional risk of anti-retroviral therapeutic failure, possibly due to drug-drug interaction involving up-regulation of metabolic clearance.
References
1 Gougeon ML, Montagnier L. Programmed cell death as a mechanism of CD4 and CD8 T-cell deletion in AIDS: molecular control and effect of highly active anti-retroviral therapy. Ann NY Acad Sci 1999; 887: 199–212. 10.1111/j.1749-6632.1999.tb07934.xSearch in Google Scholar
2 Dobmeyer TS, Findhammer S, Dobmeyer JM, Klein SA, Raffael B, Hoelzer D, et al. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 1997; 22: 775–85. 10.1016/S0891-5849(96)00403-0Search in Google Scholar
3 Li-Weber M, Laur O, Dern K, Krammer PH. T-cell activation-induced and HIV tat-enhanced CD95 (APO-1/Fas) ligand transcription involves NF-kappaB. Eur J Immunol 2000; 30: 661–70. 10.1002/1521-4141(200002)30:2<661::AID-IMMU661>3.0.CO;2-LSearch in Google Scholar
4 Eichhorst ST, Muller M, Li-Weber M, Schulze-Bergkamen H, Angel P, Krammer PH. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 2000; 20: 7826–37. 10.1128/MCB.20.20.7826-7837.2000Search in Google Scholar
5 Kramer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789–95. 10.1038/35037728Search in Google Scholar
6 Traber MG, Packer L. Vitamin E: beyond antioxidant function. Am J Clin Nutr 1995; 62: 1501S–9S. 10.1093/ajcn/62.6.1501SSearch in Google Scholar
7 Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141–9. 10.1146/annurev.iy.12.040194.001041Search in Google Scholar
8 Constans J, Pellegrin JL, Peuchant E, Dumon MF, Sergeant C, Simonoff M, et al. Tumor necrosis factor-alpha in human immunodeficiency virus-infected patients: correlations with opportunistic infections and immunologic status. J Infect Dis 1993; 168: 1327–8. 10.1093/infdis/168.5.1327Search in Google Scholar
9 Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection – correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994; 169: 420–4. 10.1093/infdis/169.2.420Search in Google Scholar
10 Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 495–504. 10.1016/0092-8674(95)90070-5Search in Google Scholar
11 Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995; 81: 505–12. 10.1016/0092-8674(95)90071-3Search in Google Scholar
12 Saikumar P, Dong Z, Mikailow V, Denton M, Weinberg JM, Venkatachalam MA. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 1999; 107: 489–506. 10.1016/S0002-9343(99)00259-4Search in Google Scholar
13 Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000; 407: 777–83. 10.1038/35037717Search in Google Scholar
14 Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770–6. 10.1038/35037710Search in Google Scholar
15 Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998; 67: 143–7. 10.1093/ajcn/67.1.143Search in Google Scholar
16 Treitinger A, Spada C, Verdi JC, Miranda AF, Oliveira OV, Silveira MV, et al. Decreased antioxidant defence in individuals infected by the human immunodeficiency virus. Eur J Clin Invest 2000; 30: 454–9. 10.1046/j.1365-2362.2000.00642.xSearch in Google Scholar
17 Allard JP, Aghdassi E, Chau J, Tam, C, Kovacs CM, Salit IE, Walmsley SL. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 1998; 12: 1653–9. 10.1097/00002030-199813000-00013Search in Google Scholar
18 Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J Biol Chem 1991; 266: 6188–94. 10.1016/S0021-9258(18)38102-XSearch in Google Scholar
19 Baier-Bitterlich G, Uberall F, Bauer B, Fresser F, Wachter H, Grunicke H, et al. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 1996; 16: 1842–50. 10.1128/MCB.16.4.1842Search in Google Scholar PubMed PubMed Central
20 Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000; 404: 402–7. 10.1038/35006090Search in Google Scholar PubMed
21 Thurnham DI, Smith E, Flora PS. Concurrent liquid chromatographic assay of retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988; 34: 377–81. 10.1093/clinchem/34.2.377Search in Google Scholar
22 Tang AM, Graham NM, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS 1997; 11: 613–20. 10.1097/00002030-199705000-00009Search in Google Scholar
23 Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117–22. 10.1038/373117a0Search in Google Scholar
24 Sarih M, Maâtaoui WE, Benslimane A. Analysis of apoptosis and a Th1/Th2 phenotype in HIV-infected patients. Immunol Lett 1996; 50: 125–9. 10.1016/0165-2478(96)02509-6Search in Google Scholar
25 Blanco J, Barretina J, Cabrera C, Gutiérrez A, Clotet B, Esté JA. CD4+ and CD8+ T cell death during human immunodeficiency virus infection in vitro. Virology 2001; 285: 356–65. 10.1006/viro.2001.0969Search in Google Scholar
26 Baggio GL, Verdi JC, Treitinger A, Cunha J, Ferreira SI, Spada C. Cellular viability of lymphocytes as an auxiliary for the institution of antiretroviral therapy in the human immunodeficiency virus infection. Revista Brasilieira de Análises Clínicas (RBAC) 2005: in press. Search in Google Scholar
27 Arnoult D, Petit F, Jean-Daniel Lelievre JD, Estaquier J. Mitochondria in HIV-1-induced apoptosis. Biochem Biophys Res Commun 2003; 304: 561–74. 10.1016/S0006-291X(03)00629-6Search in Google Scholar
28 Gius D, Botero A, Shah S, Curry HA. Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. Toxicol Lett 1999; 106: 93–106. 10.1016/S0378-4274(99)00024-7Search in Google Scholar
29 Mercurio F, Manning AM. NF-kappaB as a primary regulator of the stress response. Oncogene 1999; 18: 6163–71. 10.1038/sj.onc.1203174Search in Google Scholar PubMed
30 Johnson N, Parkin JM. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 1998; 113: 229–34. 10.1046/j.1365-2249.1998.00640.xSearch in Google Scholar PubMed PubMed Central
31 Chavan SJ, Tamma SL, Kaplan M, Gersten M, Pahwa SG. Reduction in T cell apoptosis in patients with HIV disease following anti-retroviral therapy. Clin Immunol 1999; 93: 24–33. 10.1006/clim.1999.4770Search in Google Scholar PubMed
32 Pitrak DL, Bolaños J, Hershow R, Novak RM. Discordant CD4 T lymphocyte responses to anti-retroviral therapy for HIV infection are associated with ex-vivo rates of apoptosis. AIDS 2001; 15: 1317–9. 10.1097/00002030-200107060-00018Search in Google Scholar
33 Traber MG. Vitamin E, nuclear receptors and xenobiotic metabolism. Arch Biochem Biophys 2003; 423: 6–11. 10.1016/j.abb.2003.10.009Search in Google Scholar
34 Brigelius-Flohé R. Vitamin E and drug metabolism. Biochem Biophys Res Commun 2003; 305: 737–40. 10.1016/S0006-291X(03)00811-8Search in Google Scholar
35 Landes N, Pfluger P, Klutch D. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharm, 2003; 65: 269–73. 10.1016/S0006-2952(02)01520-4Search in Google Scholar
36 Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, et al. Initial increase in blood CD4+ lym-phocytes after HIV anti-retroviral therapy reflectsredistribution from lymphoid tissues. J Clin Invest 1999; 103: 1391–8. 10.1172/JCI5863Search in Google Scholar
37 Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4: 208–14. 10.1038/nm0298-208Search in Google Scholar
38 Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001; 15: 1749–56. 10.1097/00002030-200109280-00002Search in Google Scholar
39 Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carrol A, et al. The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active anti-retroviral therapy. AIDS 2003; 17: 963–9. 10.1097/00002030-200305020-00004Search in Google Scholar
40 Barroso MP, Gómez-Díaz C, López-Lluch G, Malagón MM, Crane FL, Navas P. Ascorbate and alpha-tocopherol prevent apoptosis induced by serum removal independent of bcl-2. Arch Biochem Biophys 1997; 343: 243–8. 10.1006/abbi.1997.0170Search in Google Scholar
41 Jaruga P, Jaruga B, Gackowski D, Olczak A, Halota W, Pawlowska M, et al. Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic Biol Med 2002; 32: 414–20. 10.1016/S0891-5849(01)00821-8Search in Google Scholar
42 Bauer MK, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 1998; 273: 8048–55. 10.1074/jbc.273.14.8048Search in Google Scholar PubMed
43 Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 1998; 273: 13245–54. 10.1074/jbc.273.21.13245Search in Google Scholar PubMed
44 Li-Weber M, Weigand MA, Giasi M, Suss D, Treiber MK, Baumann S, et al. Vitamin inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest 2002; 110: 681–90. 10.1172/JCI0215073Search in Google Scholar
45 McComsey G, Southwell H, Gripsohover B, Salata R, Valdez E. Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy. J AIDS 2003; 33: 605–7. 10.1097/00126334-200308150-00009Search in Google Scholar PubMed
46 Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123–6. 10.1038/373123a0Search in Google Scholar PubMed
© by Walter de Gruyter Berlin New York
